Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huihui Chi

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Blood|May 19, 2025
Ruxolitinib Targets JAK-STAT Signaling to Modulate Neutrophil Activation in Refractory Macrophage Activation SyndromeYuning Ma, Xia Chen, Mengyan Wang, et al.
Journal of Autoimmunity|February 5, 2022
Enhanced type I interferon signature induces neutrophil extracellular traps enriched in mitochondrial DNA in adult-onset Still's diseaseYuning Ma, Mengyan Wang, Jinchao Jia, et al.
Clinical Rheumatology|May 25, 2020
Anxiety and depression in adult-onset Still's disease patients and associations with health-related quality of lifeHuihui Chi, Haiyan Jin, Zhihong Wang, et al.
BMC Medicine|December 21, 2023
Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's diseaseJinchao Jia, Mengyan Wang, Yuning Ma, et al.
Rheumatology (Oxford, England)|April 27, 2026
Benefits of adjunct plasma exchange in idiopathic inflammatory myopathy with anti-signal recognition particle antibodies：a real-world studyYunjing Shi, Jianhui Guo, Jia Sun, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 2023
Risk factors in antiphospholipid antibody-associated valvular heart disease: A 383-patient cohort studyHaoyu Pan, Zetao Ding, Zhixia Yang, et al.
Iscience|December 24, 2025
TLR9 decreases FOXO3 expression to prevent excessive inflammation in macrophage activation syndromeMengyan Wang, Yuning Ma, Jianfen Meng, et al.
Rheumatology (Oxford, England)|January 25, 2021
Characteristics and risk factors of relapses in patients with adult-onset Still's disease: a long-term cohort studyJianfen Meng, Huihui Chi, Zhihong Wang, et al.
Rheumatology (Oxford, England)|July 22, 2022
COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective studyHaoyu Pan, Zihan Tang, Jialin Teng, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2026
A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still's Disease-like Autoinflammatory SyndromeLongfang Chen, Qihua Dai, Yu Xiao, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Blood|May 19, 2025
Ruxolitinib Targets JAK-STAT Signaling to Modulate Neutrophil Activation in Refractory Macrophage Activation SyndromeYuning Ma, Xia Chen, Mengyan Wang, et al.
Journal of Autoimmunity|February 5, 2022
Enhanced type I interferon signature induces neutrophil extracellular traps enriched in mitochondrial DNA in adult-onset Still's diseaseYuning Ma, Mengyan Wang, Jinchao Jia, et al.
Clinical Rheumatology|May 25, 2020
Anxiety and depression in adult-onset Still's disease patients and associations with health-related quality of lifeHuihui Chi, Haiyan Jin, Zhihong Wang, et al.
BMC Medicine|December 21, 2023
Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's diseaseJinchao Jia, Mengyan Wang, Yuning Ma, et al.
Rheumatology (Oxford, England)|April 27, 2026
Benefits of adjunct plasma exchange in idiopathic inflammatory myopathy with anti-signal recognition particle antibodies：a real-world studyYunjing Shi, Jianhui Guo, Jia Sun, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 2023
Risk factors in antiphospholipid antibody-associated valvular heart disease: A 383-patient cohort studyHaoyu Pan, Zetao Ding, Zhixia Yang, et al.
Iscience|December 24, 2025
TLR9 decreases FOXO3 expression to prevent excessive inflammation in macrophage activation syndromeMengyan Wang, Yuning Ma, Jianfen Meng, et al.
Rheumatology (Oxford, England)|January 25, 2021
Characteristics and risk factors of relapses in patients with adult-onset Still's disease: a long-term cohort studyJianfen Meng, Huihui Chi, Zhihong Wang, et al.
Rheumatology (Oxford, England)|July 22, 2022
COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective studyHaoyu Pan, Zihan Tang, Jialin Teng, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2026
A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still's Disease-like Autoinflammatory SyndromeLongfang Chen, Qihua Dai, Yu Xiao, et al.
Pageof 6